annual SGA:
$266.13M+$52.24M(+24.42%)Summary
- As of today (May 29, 2025), BCRX annual SGA is $266.13 million, with the most recent change of +$52.24 million (+24.42%) on December 31, 2024.
- During the last 3 years, BCRX annual SGA has risen by +$147.31 million (+123.98%).
- BCRX annual SGA is now at all-time high.
Performance
BCRX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$82.47M+$2.00M(+2.48%)Summary
- As of today (May 29, 2025), BCRX quarterly SGA is $82.47 million, with the most recent change of +$2.00 million (+2.48%) on March 31, 2025.
- Over the past year, BCRX quarterly SGA has increased by +$22.98 million (+38.62%).
- BCRX quarterly SGA is now at all-time high.
Performance
BCRX quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$7.01B-$53.47M(-0.77%)Summary
- As of today (May 29, 2025), BCRX TTM SGA is -$7.01 billion, with the most recent change of -$53.47 million (-0.77%) on March 31, 2025.
- Over the past year, BCRX TTM SGA has dropped by -$7.24 billion (-3209.51%).
- BCRX TTM SGA is now -43455.93% below its all-time high of -$16.10 million.
Performance
BCRX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
BCRX Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.4% | +38.6% | -3209.5% |
| 3 y3 years | +124.0% | +140.6% | -5453.6% |
| 5 y5 years | +616.9% | +419.8% | -10000.0% |
BCRX Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +124.0% | at high | +140.6% | -45.8% | at low |
| 5 y | 5-year | at high | +616.9% | at high | +494.0% | -108.9% | at low |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | <-9999.0% | at low |
BCRX Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $82.47M(+2.5%) | $289.24M(+8.6%) |
| Dec 2024 | $266.13M(+24.4%) | $80.47M(+23.6%) | $266.26M(+6.4%) |
| Sep 2024 | - | $65.08M(+6.3%) | $250.17M(+6.1%) |
| Jun 2024 | - | $61.21M(+2.9%) | $235.74M(+4.5%) |
| Mar 2024 | - | $59.49M(-7.6%) | $225.52M(+5.4%) |
| Dec 2023 | $213.89M(+34.2%) | $64.38M(+27.1%) | $213.89M(+7.1%) |
| Sep 2023 | - | $50.65M(-0.7%) | $199.66M(+7.4%) |
| Jun 2023 | - | $51.00M(+6.5%) | $185.94M(+7.5%) |
| Mar 2023 | - | $47.87M(-4.6%) | $172.96M(+8.5%) |
| Dec 2022 | $159.37M(+34.1%) | $50.15M(+35.8%) | $159.37M(+10.2%) |
| Sep 2022 | - | $36.92M(-2.9%) | $144.60M(+1.4%) |
| Jun 2022 | - | $38.02M(+10.9%) | $142.68M(+8.9%) |
| Mar 2022 | - | $34.28M(-3.1%) | $130.99M(+10.2%) |
| Dec 2021 | $118.82M(+74.9%) | $35.39M(+1.1%) | $118.82M(+13.8%) |
| Sep 2021 | - | $34.99M(+32.9%) | $104.42M(+20.5%) |
| Jun 2021 | - | $26.32M(+19.0%) | $86.62M(+16.8%) |
| Mar 2021 | - | $22.11M(+5.4%) | $74.18M(+9.2%) |
| Dec 2020 | $67.93M(+83.0%) | $20.99M(+22.0%) | $67.93M(+18.3%) |
| Sep 2020 | - | $17.20M(+23.9%) | $57.43M(+10.5%) |
| Jun 2020 | - | $13.88M(-12.5%) | $51.97M(+11.2%) |
| Mar 2020 | - | $15.87M(+51.3%) | $46.75M(+25.9%) |
| Dec 2019 | $37.12M(+25.8%) | $10.49M(-10.6%) | $37.12M(+19.3%) |
| Sep 2019 | - | $11.73M(+35.5%) | $31.12M(+14.0%) |
| Jun 2019 | - | $8.66M(+38.8%) | $27.31M(-3.0%) |
| Mar 2019 | - | $6.24M(+38.9%) | $28.14M(-4.6%) |
| Dec 2018 | $29.51M(+111.8%) | $4.49M(-43.3%) | $29.51M(-0.7%) |
| Sep 2018 | - | $7.92M(-16.5%) | $29.72M(+18.2%) |
| Jun 2018 | - | $9.49M(+24.7%) | $25.14M(+36.0%) |
| Mar 2018 | - | $7.61M(+62.0%) | $18.48M(+32.7%) |
| Dec 2017 | $13.93M(+23.8%) | $4.70M(+40.5%) | $13.93M(+18.1%) |
| Sep 2017 | - | $3.34M(+18.0%) | $11.80M(+5.2%) |
| Jun 2017 | - | $2.83M(-7.3%) | $11.21M(+1.0%) |
| Mar 2017 | - | $3.06M(+19.4%) | $11.10M(-1.4%) |
| Dec 2016 | $11.25M(-13.8%) | $2.56M(-7.1%) | $11.25M(-1.4%) |
| Sep 2016 | - | $2.76M(+1.2%) | $11.41M(+0.2%) |
| Jun 2016 | - | $2.72M(-15.2%) | $11.39M(-6.6%) |
| Mar 2016 | - | $3.21M(+18.0%) | $12.20M(-6.5%) |
| Dec 2015 | $13.05M(+74.9%) | $2.72M(-0.4%) | $13.05M(+5.4%) |
| Sep 2015 | - | $2.73M(-22.7%) | $12.37M(+8.0%) |
| Jun 2015 | - | $3.53M(-13.0%) | $11.46M(+15.3%) |
| Mar 2015 | - | $4.06M(+98.3%) | $9.93M(+33.1%) |
| Dec 2014 | $7.46M(+24.2%) | $2.05M(+13.0%) | $7.46M(+9.2%) |
| Sep 2014 | - | $1.81M(-10.0%) | $6.83M(+3.5%) |
| Jun 2014 | - | $2.01M(+26.8%) | $6.60M(+9.7%) |
| Mar 2014 | - | $1.59M(+12.0%) | $6.02M(+0.2%) |
| Dec 2013 | $6.01M(-34.2%) | $1.42M(-10.2%) | $6.01M(-31.9%) |
| Sep 2013 | - | $1.58M(+10.3%) | $8.82M(-0.1%) |
| Jun 2013 | - | $1.43M(-9.3%) | $8.83M(-2.0%) |
| Mar 2013 | - | $1.58M(-62.7%) | $9.01M(-1.3%) |
| Dec 2012 | $9.13M(-23.8%) | $4.23M(+166.1%) | $9.13M(+31.3%) |
| Sep 2012 | - | $1.59M(-1.1%) | $6.96M(-16.4%) |
| Jun 2012 | - | $1.61M(-5.2%) | $8.32M(-18.8%) |
| Mar 2012 | - | $1.70M(-17.6%) | $10.24M(-15.2%) |
| Dec 2011 | $11.98M(+2.2%) | $2.06M(-30.3%) | $12.08M(+10.4%) |
| Sep 2011 | - | $2.95M(-16.5%) | $10.94M(-7.1%) |
| Jun 2011 | - | $3.54M(+0.1%) | $11.78M(+2.9%) |
| Mar 2011 | - | $3.53M(+284.2%) | $11.45M(-2.3%) |
| Dec 2010 | $11.72M(+2.1%) | $919.00K(-75.8%) | $11.72M(-18.9%) |
| Sep 2010 | - | $3.79M(+18.2%) | $14.45M(+5.3%) |
| Jun 2010 | - | $3.21M(-15.5%) | $13.72M(+7.0%) |
| Mar 2010 | - | $3.80M(+4.1%) | $12.82M(+11.7%) |
| Dec 2009 | $11.48M | $3.65M(+19.0%) | $11.48M(+12.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | $3.06M(+32.5%) | $10.21M(+6.2%) |
| Jun 2009 | - | $2.31M(-5.9%) | $9.62M(-3.5%) |
| Mar 2009 | - | $2.46M(+3.4%) | $9.97M(-4.1%) |
| Dec 2008 | $10.40M(+9.9%) | $2.38M(-3.8%) | $10.40M(-1.0%) |
| Sep 2008 | - | $2.47M(-7.3%) | $10.51M(-1.2%) |
| Jun 2008 | - | $2.67M(-7.6%) | $10.63M(+6.5%) |
| Mar 2008 | - | $2.89M(+16.1%) | $9.98M(+5.4%) |
| Dec 2007 | $9.47M(+55.0%) | $2.49M(-4.2%) | $9.47M(+9.9%) |
| Sep 2007 | - | $2.60M(+28.9%) | $8.61M(+13.1%) |
| Jun 2007 | - | $2.01M(-15.1%) | $7.61M(+9.0%) |
| Mar 2007 | - | $2.37M(+45.5%) | $6.99M(+14.4%) |
| Dec 2006 | $6.11M(+65.7%) | $1.63M(+2.0%) | $6.11M(+2.7%) |
| Sep 2006 | - | $1.60M(+15.5%) | $5.95M(+15.6%) |
| Jun 2006 | - | $1.38M(-7.4%) | $5.14M(+14.6%) |
| Mar 2006 | - | $1.50M(+1.8%) | $4.49M(+21.7%) |
| Dec 2005 | $3.69M(+14.5%) | $1.47M(+84.7%) | $3.69M(+18.0%) |
| Sep 2005 | - | $795.00K(+9.4%) | $3.12M(+2.2%) |
| Jun 2005 | - | $727.00K(+4.5%) | $3.06M(-6.1%) |
| Mar 2005 | - | $696.00K(-23.2%) | $3.26M(+1.1%) |
| Dec 2004 | $3.22M(+14.6%) | $905.70K(+24.4%) | $3.22M(-6.4%) |
| Sep 2004 | - | $728.00K(-21.4%) | $3.44M(+6.2%) |
| Jun 2004 | - | $926.00K(+40.3%) | $3.24M(+13.0%) |
| Mar 2004 | - | $660.00K(-41.3%) | $2.86M(+1.9%) |
| Dec 2003 | $2.81M(-1.5%) | $1.12M(+113.8%) | $2.81M(+25.1%) |
| Sep 2003 | - | $526.00K(-4.9%) | $2.25M(-5.4%) |
| Jun 2003 | - | $553.00K(-8.9%) | $2.37M(-11.8%) |
| Mar 2003 | - | $607.00K(+8.4%) | $2.69M(-5.6%) |
| Dec 2002 | $2.86M(-6.4%) | $559.80K(-14.5%) | $2.85M(-13.6%) |
| Sep 2002 | - | $655.00K(-24.8%) | $3.30M(-1.0%) |
| Jun 2002 | - | $871.00K(+13.4%) | $3.34M(+0.2%) |
| Mar 2002 | - | $768.00K(-23.7%) | $3.33M(+0.9%) |
| Dec 2001 | $3.05M(-14.2%) | $1.01M(+46.2%) | $3.30M(+1.9%) |
| Sep 2001 | - | $689.00K(-20.3%) | $3.24M(-0.6%) |
| Jun 2001 | - | $865.00K(+17.1%) | $3.26M(-1.6%) |
| Mar 2001 | - | $739.00K(-21.7%) | $3.31M(-8.3%) |
| Dec 2000 | $3.56M(+22.7%) | $944.30K(+33.2%) | $3.61M(+10.5%) |
| Sep 2000 | - | $709.00K(-22.7%) | $3.27M(+0.3%) |
| Jun 2000 | - | $917.00K(-11.8%) | $3.26M(+0.5%) |
| Mar 2000 | - | $1.04M(+73.3%) | $3.24M(+8.0%) |
| Dec 1999 | $2.90M(-6.5%) | $600.00K(-14.3%) | $3.00M(0.0%) |
| Sep 1999 | - | $700.00K(-22.2%) | $3.00M(-14.3%) |
| Jun 1999 | - | $900.00K(+12.5%) | $3.50M(+6.1%) |
| Mar 1999 | - | $800.00K(+33.3%) | $3.30M(+6.5%) |
| Dec 1998 | $3.10M(+14.8%) | $600.00K(-50.0%) | $3.10M(0.0%) |
| Sep 1998 | - | $1.20M(+71.4%) | $3.10M(+29.2%) |
| Jun 1998 | - | $700.00K(+16.7%) | $2.40M(-11.1%) |
| Mar 1998 | - | $600.00K(0.0%) | $2.70M(-3.6%) |
| Dec 1997 | $2.70M(0.0%) | $600.00K(+20.0%) | $2.80M(0.0%) |
| Sep 1997 | - | $500.00K(-50.0%) | $2.80M(0.0%) |
| Jun 1997 | - | $1.00M(+42.9%) | $2.80M(-3.4%) |
| Mar 1997 | - | $700.00K(+16.7%) | $2.90M(+7.4%) |
| Dec 1996 | $2.70M(+22.7%) | $600.00K(+20.0%) | $2.70M(-3.6%) |
| Sep 1996 | - | $500.00K(-54.5%) | $2.80M(0.0%) |
| Jun 1996 | - | $1.10M(+120.0%) | $2.80M(+27.3%) |
| Mar 1996 | - | $500.00K(-28.6%) | $2.20M(-4.3%) |
| Dec 1995 | $2.20M(+15.8%) | $700.00K(+40.0%) | $2.30M(+15.0%) |
| Sep 1995 | - | $500.00K(0.0%) | $2.00M(+5.3%) |
| Jun 1995 | - | $500.00K(-16.7%) | $1.90M(-5.0%) |
| Mar 1995 | - | $600.00K(+50.0%) | $2.00M(+5.3%) |
| Dec 1994 | $1.90M | $400.00K(0.0%) | $1.90M(+26.7%) |
| Sep 1994 | - | $400.00K(-33.3%) | $1.50M(+36.4%) |
| Jun 1994 | - | $600.00K(+20.0%) | $1.10M(+120.0%) |
| Mar 1994 | - | $500.00K | $500.00K |
FAQ
- What is BioCryst Pharmaceuticals annual SGA?
- What is the all time high annual SGA for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual SGA year-on-year change?
- What is BioCryst Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly SGA year-on-year change?
- What is BioCryst Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals TTM SGA year-on-year change?
What is BioCryst Pharmaceuticals annual SGA?
The current annual SGA of BCRX is $266.13M
What is the all time high annual SGA for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual SGA is $266.13M
What is BioCryst Pharmaceuticals annual SGA year-on-year change?
Over the past year, BCRX annual SGA has changed by +$52.24M (+24.42%)
What is BioCryst Pharmaceuticals quarterly SGA?
The current quarterly SGA of BCRX is $82.47M
What is the all time high quarterly SGA for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly SGA is $82.47M
What is BioCryst Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, BCRX quarterly SGA has changed by +$22.98M (+38.62%)
What is BioCryst Pharmaceuticals TTM SGA?
The current TTM SGA of BCRX is -$7.01B
What is the all time high TTM SGA for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high TTM SGA is -$16.10M
What is BioCryst Pharmaceuticals TTM SGA year-on-year change?
Over the past year, BCRX TTM SGA has changed by -$7.24B (-3209.51%)